What’s new

Aprotinin 10,000 KIU/ml Injection BP

Click here to view the Summary of Product Characteristics

References

  1. Stevens LM et al. Major transfusions remain frequent despite the generalized use of tranexamic acid: an audit of 3322 patients undergoing cardiac surgery. Transfusion 2016;56:1857-65.
  2. Aprotinin 10,000 KIU/ml Injection BP Summary of Product Characteristics. Available from: https://www.medicines.org.uk/emc/product/2472/smpc. Accessed December 2020.
  3. Mehran R et al. Standardized Bleeding Definitions for Cardiovascular Clinical Trial. A Consensus Report From the Bleeding Academic Research Consortium. Circulation 2011;123:2736-2747.
  4. Gombotz H et al. The second Austrian benchmark study for blood use in elective surgery: results and practice change. Transfusion 2014;54:2646-57.
  5. Boer C et al. 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery. J Cardiothor Vasc Anesth. 2018;32:88–120.